Eric M. Dube's Stock Option Exercise at Travere Therapeutics, Inc.

The filing reports that Eric M. Dube, an officer at Travere Therapeutics, Inc., exercised stock options for 92,872 shares of common stock on October 28, 2025. The stock options were originally granted on June 16, 2025. The transaction was executed through Fidelity Brokerage Services LLC, and the aggregate market value of the shares at the time of the transaction was approximately $2,821,217.14. The filing also confirms that there were no securities sold by Dube in the past three months. This transaction is significant as it reflects the exercise of stock options by a key officer of the company.